Skip to main content

Find Clinical Trials

Home
Conditions
Leiomyosarcoma

Clinical trial condition

Leiomyosarcoma

Explore clinical trials studying Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

56 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Leiomyosarcoma trial results

Not Yet Recruiting

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

NCT06526897

Conditions: AJCC Grade 2 Sarcoma, AJCC Grade 3 Sarcoma, Adult Pleomorphic Rhabdomyosarcoma, +46 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions

NCT06521060

Conditions: Leiomyoma, Leiomyosarcoma, Neoplasms, +4 more
Locations: General hospital Prague, Czechia

View Trial Details

Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions: Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

The Kirklin Clinic at Acton Road Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

View all 381 locations

View Trial Details

Completed

Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma

NCT03526679

Conditions: Advanced Cancer, Leiomyosarcoma, Liposarcoma, +7 more
Locations: Taipei Veterans General Hospital Taipei, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

NCT03899805

Conditions: Histiocytoma, Histiocytoma, Malignant Fibrous, Leiomyosarcoma, +10 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

NCT04242238

Conditions: Advanced Sarcoma, Dedifferentiated Liposarcoma, Dermatofibrosarcoma, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma

NCT05080790

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: HELIOS Klinikum Bad Saarow Bad Saarow, Germany

Helios Klinikum Berlin-Buch Berlin, Germany

View Trial Details

Completed

A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients

NCT04811196

Conditions: Endometrial Neoplasms, Endometrial Stromal Sarcoma, Endometrial Stromal Tumors, +31 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

A Study of Nivolumab in Selected Uterine Cancer Patients

NCT03241745

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +25 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

View Trial Details

Completed

Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma

NCT01956084

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +14 more
Locations: Childrens National Medical Center Washington D.C., District of Columbia, United States

View Trial Details